anastrozole has been researched along with Porphyria, Acute Intermittent in 1 studies
Porphyria, Acute Intermittent: An autosomal dominant porphyria that is due to a deficiency of HYDROXYMETHYLBILANE SYNTHASE in the LIVER, the third enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features are recurrent and life-threatening neurologic disturbances, ABDOMINAL PAIN, and elevated level of AMINOLEVULINIC ACID and PORPHOBILINOGEN in the urine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thiery-Vuillemin, A | 1 |
| Chaigneau, L | 1 |
| Meaux-Ruault, N | 1 |
| Villanueva, C | 1 |
| N'guyen, T | 1 |
| Maurina, T | 1 |
| Stein, U | 1 |
| Lorgis, V | 1 |
| Demarchi, M | 1 |
| Pivot, X | 1 |
1 other study available for anastrozole and Porphyria, Acute Intermittent
| Article | Year |
|---|---|
Anticancer therapy in patients with porphyrias: evidence today.
Topics: Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Docetaxel; Epoetin Alfa; | 2008 |